APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Rheumatoid Arthritis Stem Cell Therapy

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rheumatoid Arthritis Stem Cell Therapy Market Outlook and Growth Opportunities 2026

Report ID 174032790420 December 2025191 pages

Choose your research edition.

Industry ResearchRheumatoid Arthritis Stem Cell Therapy Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Rheumatoid Arthritis Stem Cell Therapy Industry Growth and Trends Forecast to 203287 pages · $3,450 USDMarket StructureGlobal Rheumatoid Arthritis Stem Cell Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rheumatoid Arthritis Stem Cell Therapy Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Rheumatoid Arthritis Stem Cell Therapy Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Rheumatoid Arthritis Stem Cell Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rheumatoid Arthritis Stem Cell Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rheumatoid Arthritis Stem Cell Therapy market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rheumatoid Arthritis Stem Cell Therapy market include International Stem Cell Corporation, Mesoblast, Regeneus, ReNeuron Group, Roslin Cells and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Rheumatoid Arthritis Stem Cell Therapy market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rheumatoid Arthritis Stem Cell Therapy and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rheumatoid Arthritis Stem Cell Therapy revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Rheumatoid Arthritis Stem Cell Therapy market.

Rheumatoid Arthritis Stem Cell Therapy Segment by Company

International Stem Cell Corporation

Mesoblast

Regeneus

ReNeuron Group

Roslin Cells

Takeda

Rheumatoid Arthritis Stem Cell Therapy Segment by Type

Adipose Tissue Stem Cells

Allogeneic Mesenchymal Stem Cells

Bone Marrow Transplant

Rheumatoid Arthritis Stem Cell Therapy Segment by Application

Ambulatory Surgical Centers

Hospitals

Specialty Clinics

Rheumatoid Arthritis Stem Cell Therapy Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Rheumatoid Arthritis Stem Cell Therapy status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Rheumatoid Arthritis Stem Cell Therapy key companies, revenue, market share, and recent developments.

3. To split the Rheumatoid Arthritis Stem Cell Therapy breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Rheumatoid Arthritis Stem Cell Therapy market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rheumatoid Arthritis Stem Cell Therapy significant trends, drivers, influence factors in global and regions.

6. To analyze Rheumatoid Arthritis Stem Cell Therapy competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rheumatoid Arthritis Stem Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rheumatoid Arthritis Stem Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rheumatoid Arthritis Stem Cell Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rheumatoid Arthritis Stem Cell Therapy industry.

Chapter 3: Detailed analysis of Rheumatoid Arthritis Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Rheumatoid Arthritis Stem Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Rheumatoid Arthritis Stem Cell Therapy in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rheumatoid Arthritis Stem Cell Therapy Industry Trends Table 2. Rheumatoid Arthritis Stem Cell Therapy Industry Drivers Table 3. Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges Table 4. Rheumatoid Arthritis Stem Cell Therapy Industry Restraints Table 5. Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rheumatoid Arthritis Stem Cell Therapy Revenue Share by Company (2021-2026) Table 7. Global Rheumatoid Arthritis Stem Cell Therapy Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Rheumatoid Arthritis Stem Cell Therapy Key Company Manufacturing Base & Headquarters Table 9. Global Rheumatoid Arthritis Stem Cell Therapy Company, Product Type & Application Table 10. Global Rheumatoid Arthritis Stem Cell Therapy Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Rheumatoid Arthritis Stem Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Adipose Tissue Stem Cells Table 15. Significant Companies of Allogeneic Mesenchymal Stem Cells Table 16. Significant Companies of Bone Marrow Transplant Table 17. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type (2021-2026) Table 21. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Ambulatory Surgical Centers Table 23. Significant Companies of Hospitals Table 24. Significant Companies of Specialty Clinics Table 25. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application (2021-2026) Table 29. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application (2027-2032) Table 30. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Region (2021-2026) Table 33. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Region (2027-2032) Table 35. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Market Share by Country (2021-2026) Table 38. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Market Share by Country (2027-2032) Table 40. International Stem Cell Corporation Company Information Table 41. International Stem Cell Corporation Business Overview Table 42. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 44. International Stem Cell Corporation Recent Development Table 45. Mesoblast Company Information Table 46. Mesoblast Business Overview Table 47. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 49. Mesoblast Recent Development Table 50. Regeneus Company Information Table 51. Regeneus Business Overview Table 52. Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 54. Regeneus Recent Development Table 55. ReNeuron Group Company Information Table 56. ReNeuron Group Business Overview Table 57. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 59. ReNeuron Group Recent Development Table 60. Roslin Cells Company Information Table 61. Roslin Cells Business Overview Table 62. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 64. Roslin Cells Recent Development Table 65. Takeda Company Information Table 66. Takeda Business Overview Table 67. Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio Table 69. Takeda Recent Development Table 70. Research Programs/Design for This Report Table 71. Authors List of This Report Table 72. Secondary Sources Table 73. Primary Sources List of Figures Figure 1. Rheumatoid Arthritis Stem Cell Therapy Product Image Figure 2. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032) & (US$ Million) Figure 4. Global Rheumatoid Arthritis Stem Cell Therapy Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Adipose Tissue Stem Cells Image Figure 8. Allogeneic Mesenchymal Stem Cells Image Figure 9. Bone Marrow Transplant Image Figure 10. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type (2021-2032) Figure 13. Ambulatory Surgical Centers Image Figure 14. Hospitals Image Figure 15. Specialty Clinics Image Figure 16. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application (2021-2032) Figure 19. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 22. North America Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 28. South America Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Adipose Tissue Stem Cells
  • Allogeneic Mesenchymal Stem Cells
  • Bone Marrow Transplant
Applications
  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
Companies covered
  • International Stem Cell Corporation
  • Mesoblast
  • Regeneus
  • ReNeuron Group
  • Roslin Cells
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Rheumatoid Arthritis Stem Cell Therapy Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Rheumatoid Arthritis Stem Cell Therapy Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Rheumatoid Arthritis Stem Cell Therapy Market Dynamics
  1. 2.1 Rheumatoid Arthritis Stem Cell Therapy Industry Trends
  2. 2.2 Rheumatoid Arthritis Stem Cell Therapy Industry Drivers
  3. 2.3 Rheumatoid Arthritis Stem Cell Therapy Industry Opportunities and Challenges
  4. 2.4 Rheumatoid Arthritis Stem Cell Therapy Industry Restraints
3 Rheumatoid Arthritis Stem Cell Therapy Market by Company
  1. 3.1 Global Rheumatoid Arthritis Stem Cell Therapy Company Revenue Ranking in 2025
  2. 3.2 Global Rheumatoid Arthritis Stem Cell Therapy Revenue by Company (2021-2026)
  3. 3.3 Global Rheumatoid Arthritis Stem Cell Therapy Company Ranking (2024-2026)
  4. 3.4 Global Rheumatoid Arthritis Stem Cell Therapy Company Manufacturing Base and Headquarters
  5. 3.5 Global Rheumatoid Arthritis Stem Cell Therapy Company Product Type and Application
  6. 3.6 Global Rheumatoid Arthritis Stem Cell Therapy Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Rheumatoid Arthritis Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Rheumatoid Arthritis Stem Cell Therapy Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Rheumatoid Arthritis Stem Cell Therapy Market by Type
  1. 4.1 Rheumatoid Arthritis Stem Cell Therapy Type Introduction
  2. 4.1.1 Adipose Tissue Stem Cells
  3. 4.1.2 Allogeneic Mesenchymal Stem Cells
  4. 4.1.3 Bone Marrow Transplant
  5. 4.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type
  6. 4.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Type (2021-2032)
  8. 4.2.3 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type (2021-2032)
5 Rheumatoid Arthritis Stem Cell Therapy Market by Application
  1. 5.1 Rheumatoid Arthritis Stem Cell Therapy Application Introduction
  2. 5.1.1 Ambulatory Surgical Centers
  3. 5.1.2 Hospitals
  4. 5.1.3 Specialty Clinics
  5. 5.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application
  6. 5.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Application (2021-2032)
  8. 5.2.3 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application (2021-2032)
6 Rheumatoid Arthritis Stem Cell Therapy Regional Value Analysis
  1. 6.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region (2021-2032)
  3. 6.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region: 2021-2026
  4. 6.2.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032)
  7. 6.3.2 North America Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032)
  10. 6.4.2 Europe Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032)
  16. 6.6.2 South America Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Country, 2025 VS 2032
7 Rheumatoid Arthritis Stem Cell Therapy Country-level Value Analysis
  1. 7.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country (2021-2032)
  3. 7.2.1 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country (2021-2026)
  4. 7.2.2 Global Rheumatoid Arthritis Stem Cell Therapy Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Rheumatoid Arthritis Stem Cell Therapy Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 International Stem Cell Corporation
  2. 8.1.1 International Stem Cell Corporation Company Information
  3. 8.1.2 International Stem Cell Corporation Business Overview
  4. 8.1.3 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  5. 8.1.4 International Stem Cell Corporation Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  6. 8.1.5 International Stem Cell Corporation Recent Developments
  7. 8.2 Mesoblast
  8. 8.2.1 Mesoblast Company Information
  9. 8.2.2 Mesoblast Business Overview
  10. 8.2.3 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Mesoblast Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  12. 8.2.5 Mesoblast Recent Developments
  13. 8.3 Regeneus
  14. 8.3.1 Regeneus Company Information
  15. 8.3.2 Regeneus Business Overview
  16. 8.3.3 Regeneus Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Regeneus Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  18. 8.3.5 Regeneus Recent Developments
  19. 8.4 ReNeuron Group
  20. 8.4.1 ReNeuron Group Company Information
  21. 8.4.2 ReNeuron Group Business Overview
  22. 8.4.3 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ReNeuron Group Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  24. 8.4.5 ReNeuron Group Recent Developments
  25. 8.5 Roslin Cells
  26. 8.5.1 Roslin Cells Company Information
  27. 8.5.2 Roslin Cells Business Overview
  28. 8.5.3 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roslin Cells Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  30. 8.5.5 Roslin Cells Recent Developments
  31. 8.6 Takeda
  32. 8.6.1 Takeda Company Information
  33. 8.6.2 Takeda Business Overview
  34. 8.6.3 Takeda Rheumatoid Arthritis Stem Cell Therapy Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Takeda Rheumatoid Arthritis Stem Cell Therapy Product Portfolio
  36. 8.6.5 Takeda Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst